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Abstract 
We carried out both a pair-wise and a Bayesian network meta-analysis, on 38 randomised trials, 
to assess how volatile-based anaesthesia (desflurane, isoflurane or sevoflurane) and total 
intravenous anaesthesia (TIVA) influence patients’ survival after cardiac surgery. A network 
meta-analysis allow to compare different treatments that were never properly compared. On the 
basis of statistical inference, it is possible to establish which treatment is superior reaching, 
through indirect comparison, reliable conclusions otherwise difficult to achieve. The standard 
meta-analysis showed that the use of a volatile agent was associated with a reduction in 
mortality when compared to TIVA at the longest follow-up available (25/1994 [1.3%] in the 
volatile group versus 43/1648 [2.6%] in the TIVA group, odds ratio=0.51, 95% confidence 
interval 0.33-0.81, p for effect=0.004). The Bayesian network meta-analysis showed that 
sevoflurane (posterior mean of odds ratio =0.31, 95% credible interval 0.14-0.64) and 
desflurane (posterior mean of odds ratio =0.43, 95% credible interval 0.21-0.82) were 
individually associated with a reduction in mortality when compared to TIVA. Anaesthesia 
with volatile agents appears to reduce mortality after cardiac surgery when compared to TIVA, 
especially when sevoflurane or desflurane are used.  
 
Introduction 
Volatile agents have documented pharmacological, non-anesthetic properties conferring cardiac 
protection and influencing perioperative and long term clinically relevant outcomes. Meta-
analyses offer a quick and cheap method to improve clinical decision making. However, head-
to-head treatment comparisons are not always available or conclusive. In this case network 
meta-analysis [1-3] can provide estimates of treatment efficacy of multiple treatment regimens. 
In doing so, it is possible to establish which treatment is superior reaching, through indirect 
comparisons, reliable conclusions otherwise difficult to achieve. To perform a network meta-
analysis, it is indispensable that the consistency equation (θBC=θAC-θBA) is satisfied. This means 
that, if the AB and AC trials are comparable in effect modifiers (are similar), an indirect 
estimate for the true difference effect between the treatment B versus C (θBC) can be obtained 
from the direct estimates of A versus B (θBA) and from direct estimates of A versus C (θAC). 
Hence, it is important that the indirect estimate is not biased and that there is no divergence 
between the direct and indirect comparisons [1].  
In this work, we carried out both a pair-wise and a Bayesian network meta-analysis to assess 
how anaesthetic drugs influence patients’ survival after cardiac surgery. The advantage of the 
Bayesian approach is that it allows for the incorporation, into the random-effect model, of the 
between studies heterogeneity degree, including a prior distribution for it and overcoming the 
problems related to the choice of variance estimate methods in the “classical” inference. 
The primary objective of this study was therefore to determine whether anaesthetic techniques 
(volatile-based anaesthesia versus total intravenous anaesthesia - TIVA) confer a survival 
advantage for patients undergoing cardiac surgery. A secondary aim was to explore whether a 
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specific volatile (desflurane, isoflurane or sevoflurane) or TIVA agent is associated with an 
improved survival. 
 
Methods 
Pertinent studies were independently searched in BioMedCentral, MEDLINE/PubMed, 
Embase, and the Cochrane Central Register. Literature searches were last updated to June 1st 
2012. No language restriction was enforced. The following inclusion criteria were used for 
potentially relevant studies: random allocation to treatment and comparison between a TIVA 
and an anaesthesia plan including administration of isoflurane, desflurane or sevoflurane or a 
comparison between volatile agents, performed in cardiac surgical patients with no restriction 
in dose and time of administration. The exclusion criteria were duplicate publications, 
nonhuman experimental studies and lack of outcome data.  
The standard pair-wise meta-analysis was performed in compliance with The Cochrane 
Collaboration standards [4]. The internal validity was critically evaluated judging the risk of 
selection-, performance-, attrition-, detection- and reporting-bias of each trial included. The 
evidence of publication bias was assessed by Peters regression asymmetry test and Begg 
adjusted-rank correlation test. A nonparametric trim-and-fill rank-based technique was also 
performed. Heterogeneity between studies was evaluated using the p-value from the Cochran Q 
statistic and the inconsistency index (I2) [4]. Mortality data from individual studies were 
analyzed in order to compute pooled OR with pertinent 95% confidence intervals (CI), using 
the inverse of variance method with a fixed-effect model in case of low statistical inconsistency 
(I2 ≤25%) or using the DerSimonian-Laird method with a random-effect model.  
In the Bayesian network meta-analyses [2,3], each arm of the trials was classified according to 
its primary treatment strategy: 1) TIVA, 2) isoflurane, 3) desflurane and 4) sevoflurane. To 
assess the consistency assumption (no discrepancy between direct and indirect comparisons) 
we proposed and implemented the posterior probability check method [5] to compare the 
difference in residual deviance between the consistency model (which the indirect treatment 
effects by consistency equation) with the inconsistency one (which estimates all the relative 
effects for all the treatment contrasts). 
The network analysis was carried out modeling the binary outcome mortality with a Bayesian 
hierarchical model (binomial model with logit link function) using a Markov chain Monte 
Carlo (MCMC) approach. We used non-informative priors (Normal distribution with mean 
equal to 0 and variance equal to 0.0001)to produce the posterior distributions for the treatment 
effect in the reference group (TIVA) and the treatment difference effects. To overcome the 
zero-cell count problem, we ran the random-effect model with a more informative prior 
(Inverse-Gamma distribution) on the variance parameter [3]. Pooled ORs were estimated from 
the mean of the posterior distribution obtained with the Bayesian approach.  
After confirming the consistency hypothesis [6], the indirect estimate was calculated as 
difference from the appropriate direct estimates; the corresponding 95% credibility interval 
(CrI) was obtained by normal approximation. We considered models where the between trials 
variance is homogeneous across treatment contrasts. We took into account the correlation 
between the treatment difference effect for each group of multi-arm trials. We selected the 
fixed-effect model, which assume the between trials variance equal to zero, or the random-
effect model, which assumes a different underlying effect for each study, calculating the 
posterior mean of the residual deviance (Dres) and the Deviance Information Criterion (DIC) 
statistic [3]. To explore the relation between log-risk of mortality and the length of study 
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follow-up, we performed a Bayesian meta-regression analysis. Sensitivity analyses were 
performed by analyzing data from studies with a low risk of bias, or by sequentially removing 
each study from the overall dataset, or by changing priors. 
The statistical analysis was performed by STATA (release 11, College Station, TX) and 
winBUGS (release 1.4, freeware available by BUGS project). 
 
Results 
Database searches, snowballing and contacts with experts yielded a total of 2630 citations. 
Excluding 2518 non-pertinent titles or abstracts, and other 74 studies because of their non-
experimental design or because of duplicate publications, we identified 38 eligible randomised 
clinical trials (all the study references are available from the authors). 
The 38 included trials randomized 3,996 patients including 1,648 (41%) receiving TIVA and 
2,348 (59%) receiving volatile agents. In details 622 (16%) patients received isoflurane, 701 
(17%) received desflurane and 1,025 (26%) received sevoflurane. The trials included a median 
of 60 (range 20-414) randomised patient and were published between 1991 and 2012. Clinical 
heterogeneity was mostly due to control treatment and follow-up duration (median: 14 days, 
range: from 4 hours after surgery to 1 year). Figure 1 reports the network configuration and 
results from the standard meta-analyses on each contrast.  
The overall standard meta-analysis showed that the use of volatile agents (isoflurane, 
desflurane, or sevoflurane) was associated with a reduction in mortality when compared to 
TIVA at the longest follow-up available (25/1994 [1.3%] in the volatile group versus 43/1648 
[2.6%] in the TIVA arm, OR=0.51, 95% CI 0.33-0.81, p for effect =0.004, p for heterogeneity 
=0.9, I2=0% with 35 studies included). Visual inspection of funnel plot did not identify an 
important skewed or asymmetrical shape. Since the quantitative evaluation suggested a possible 
presence of publication bias, as measured by Peters’ test (p=0.02) and Begg’ test (p=0.18), we 
used the trim-and-fill approach to confirm the results of our meta-analysis after adjusting for 
the presence of unpublished studies (OR=0.42, 95% CI 0.28-0.64, p for effect <0.001, p for 
heterogeneity =0.9, I2=0%, with 13 studies added).  
In the Bayesian network meta-analysis, the fit of the fixed- (Dres=127.5 and DIC=149.4) and 
random- (Dres=126.5 and DIC=150.1) effects models was similar. Hence, we selected the 
former model, which provided a slight increase in precision. We confirmed the consistency 
assumption (probability in favors of inconsistency model equal to 0.03). The results showed 
that the use of sevoflurane (posterior mean of OR =0.31, 95% CrI 0.14-0.64) and desflurane 
(posterior mean of OR =0.43, 95% CrI 0.21-0.82) was associated with a reduction in mortality 
when compared to TIVA at the longest follow-up available. When the largest trial was 
removed, we found that only the use of desflurane was associated with a significant reduction 
in mortality respect to TIVA (posterior mean of OR =0.30, 95% CrI 0.09-0.88). Furthermore, 
Bayesian meta-regressions of average follow-up against log-risk of mortality showed no 
significant effect for time on mortality (regression coefficient =-0.0008, CrI -0.004 to 0.002). 
The calculation of the posterior distribution of the probability to be the best and the worst, 
revealed a trend of TIVA to be the worst in terms of long survival after cardiac surgery. The 
sensitivity analysis did not show differences in the magnitude of effects. 
 
Discussion 
The present work shows that volatile anesthetics improve survival in cardiac surgery when 
compared to TIVA. No evidence-based data exist to suggest that one volatile agent (isoflurane, 
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desflurane, or sevoflurane) is more beneficial than the others, but there is initial evidence 
suggesting that TIVA is detrimental when compared to desflurane and sevoflurane.  
Several limitations are acknowledged. Bayesian network meta-analysis incorporates both the 
direct and indirect comparisons between treatments. However, indirect evidence is susceptible 
to confounding and thus should be interpreted with caution since it does not always agree with 
the corresponding direct estimates. Although the consistency hypothesis was not rejected, 
additional methodological and empirical work needs to be done to evaluate the direct and 
indirect comparisons across a different types of interventions. Furthermore, Bayesian network 
meta-analyses assume that patients enrolled in the individual studies could have been sampled 
from the same theoretical population, and that similar comparators between different trials have 
a consistent risk-benefit ratio. Traditional limitations of meta-analyses (i.e. variations in the 
treatment regimens, in the populations or major subgroups within trials or in the conduct of the 
studies) apply to Bayesian network meta-analysis too. In particular, by removing the largest 
trial from the meta-analysis, only the use of desflurane was still associated with a significant 
reduction in mortality as compared to TIVA. Since the evidence comes from small RCTs, it is 
imperative to conduct a large, multicenter trial to confirm that survival is significantly 
influenced by the choice of the anesthetic. 
 
Figure 1: Network configuration. Head-to-head comparisons and number of studies for each 
contrast. 
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